Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction.

J Am Heart Assoc · 2019 · PMC6761667 · PMID 31340693

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP =0.09so close (0.05 < p ≤ 0.1)

The mean dP/dT max was 1182.2 ± 185.8 mm Hg/s in the IBR‐MSC group and 852.9 ± 63.6 mm Hg/s in the IBR‐Placebo group; this difference did not reach statistical significance ( P =0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.